Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease

Association of single nucleotide polymorphism rs6903956 on chromosome 6p24.1 with coronary artery disease and lipid levels in different ethnic groups of the Singaporean population

(2013) Naeimeh Tayebi et al.   CLINICAL BIOCHEMISTRY

The effect of curcumin on sepsis-induced acute lung injury in a rat model through the inhibition of the TGF-β1/SMAD3 pathway

(2013) Fang Xu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Genetics of Human Cardiovascular Disease

(2012) Sekar Kathiresan et al.   CELL

Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-β/Smad3-treated medial smooth muscle cells

(2012) Shakti A. Goel et al.   CELLULAR SIGNALLING

Genetic Basis of Atherosclerosis: Insights From Mice and Humans

(2012) Ioannis M. Stylianou et al.   CIRCULATION RESEARCH

Pathophysiology of Atherosclerosis: The Role of Inflammation

(2012) Dimitris Tousoulis et al.   CURRENT PHARMACEUTICAL DESIGN

Reactive oxygen species in cardiovascular disease

(2011) Koichi Sugamura et al.   FREE RADICAL BIOLOGY AND MEDICINE

Transforming growth factor (TGF)-β signaling in cardiac remodeling

(2010) Marcin Dobaczewski et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Heart Disease and Stroke Statistics—2009 Update

(2009) et al.   CIRCULATION

Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation

(2009) Rachel S. Edlin et al.   JOURNAL OF VASCULAR SURGERY

TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway

(2008) Filippo Caraci et al.   NEUROBIOLOGY OF DISEASE